Antimalarial drug resistance: A review of the biology and strategies to delay emergence and spread

International Journal of Antimicrobial Agents

Volumn 41, Issue 4, 2013, Pages 311-317

  Klein, E Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Artemisinin; Drug resistance; Malaria; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ATOVAQUONE; CHLOROQUINE; MEFLOQUINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; GENE MUTATION; HUMAN; MALARIA; MALARIA CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE IMMUNITY; PARASITE LOAD; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

EID: 84875371577     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.12.007     Document Type: Short Survey

References (124)

1. World Health and Organization World malaria report 2011 2011 WHO Geneva, Switzerland
2. C.J.L. Murray, L.C. Rosenfeld, S.S. Lim, K.G. Andrews, K.J. Foreman, and D. Haring Global malaria mortality between 1980 and 2010: a systematic analysis Lancet 379 2012 413 431
3. C.D. Mathers, A.D. Lopez, and C.J. Murray The burden of disease and mortality by condition: data, methods, and results for 2001 A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J.L. Murray, Global burden of disease and risk factors 2006 The International Bank for Reconstruction and Development/The World Bank Washington, DC 45 240
4. D. Payne Spread of chloroquine resistance in Plasmodium falciparum Parasitol Today 3 1987 241 246
5. C. Roper, R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, and F. Mosha Antifolate antimalarial resistance in southeast Africa: a population-based analysis Lancet 361 2003 1174 1181
6. S. Nair, J.T. Williams, A. Brockman, L. Paiphun, M. Mayxay, and P.N. Newton A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites Mol Biol Evol 20 2003 1526 1536
7. World Health and Organization Guidelines for the treatment of malaria 2006 WHO Geneva, Switzerland
8. A.M. Dondorp, S. Yeung, L. White, C. Nguon, N.P.J. Day, and D. Socheat Artemisinin resistance: current status and scenarios for containment Nat Rev Microbiol 8 2010 272 280
9. A.P. Phyo, S. Nkhoma, K. Stepniewska, E.A. Ashley, S. Nair, and R. McGready Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study Lancet 379 2012 1960 1966
10. P. Olliaro, and T.N.C. Wells The global portfolio of new antimalarial medicines under development Clin Pharmacol Ther 85 2009 584 595
11. M. Schlitzer Antimalarial drugs - what is in use and what is in the pipeline Arch Pharm (Weinheim) 341 2008 149 163
12. R.K. Mehlotra, and P.A. Zimmerman Resistance to antimalarial drugs: parasite and host genetic factors K.R. Dronamraju, P. Arese, Malaria: genetic and evolutionary aspects 2006 Springer New York, NY
13. A.F. Cowman The molecular basis of resistance to the sulfones, sulfonamides, and dihydrofolate reductase inhibitors I. Sherman, Malaria parasite biology, pathogenesis, and protection 1998 American Society for Microbiology Washington, DC 317 330
14. N.J. White Antimalarial drug resistance J Clin Invest 113 2004 1084 1092
15. G. Dorsey, D.A. Fidock, T.E. Wellems, and P.J. Rosenthal Mechanisms of quinoline resistance P. Rosenthal, Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery 2001 Humana Press, Inc. Totowa, NJ 153 172
16. C.V. Plowe Folate antagonists and mechanisms of resistance P. Rosenthal, Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery 2001 Humana Press, Inc. Totowa, NJ 173 190
17. R. Hayward, K.J. Saliba, and K. Kirk pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum Mol Microbiol 55 2005 1285 1295
18. J.M. Peters, N. Chen, M. Gatton, M. Korsinczky, E.V. Fowler, and S. Manzetti Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum Antimicrob Agents Chemother 46 2002 2435 2441
19. M.K. Laufer, P.C. Thesing, N.D. Eddington, R. Masonga, F.K. Dzinjalamala, and S.L. Takala Return of chloroquine antimalarial efficacy in Malawi N Engl J Med 355 2006 1959 1966
20. L. De-quan, L. Rui-jun, R. Dao-xing, G. Da-qing, Z. Chun-yong, and Q. Chi-ping Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China Bull World Health Organ 73 1995 483 486
21. I.M. Hastings A model for the origins and spread of drug-resistant malaria Parasitology 115 1997 133 141
22. N. White Delaying antimalarial drug resistance with combination chemotherapy Parassitologia 41 1999 301 308
23. N.J. White Preventing antimalarial drug resistance through combinations Drug Resist Updat 1 1998 3 9
24. National Research and Council Saving lives, buying time: economics of malaria drugs in an age of resistance 2004 The National Academies Press Washington, DC
25. N.J. White, and W. Pongtavornpinyo The de novo selection of drug-resistant malaria parasites Proc Biol Sci 270 2003 545 554
26. T. Smith, J.A. Schellenberg, and R. Hayes Attributable fraction estimates and case definitions for malaria in endemic areas Stat Med 13 1994 2345 2358
27. D.L. Smith, J. Dushoff, R.W. Snow, and S.I. Hay The entomological inoculation rate and Plasmodium falciparum infection in African children Nature 438 2005 492 495
28. D.E. Eyles, and M.D. Young The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host J Natl Malar Soc 10 1951 327 336
29. N. White Antimalarial drug resistance and combination chemotherapy Philos Trans R Soc Lond B Biol Sci 354 1999 739 749
30. D.J. Austin, K.G. Kristinsson, and R.M. Anderson The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance Proc Natl Acad Sci USA 96 1999 1152 1156
31. E. Klein, R. Laxminarayan, D.L. Smith, and C. Gilligan Economic incentives and mathematical models of disease Environ Dev Econ 12 2007 707 732
32. C. Morris, S. Duparc, I. Borghini-Fuhrer, D. Jung, C.-S. Shin, and L. Fleckenstein Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration Malar J 10 2011 263
33. N.J. White Assessment of the pharmacodynamic properties of antimalarial drugs in vivo Antimicrob Agents Chemother 41 1997 1413 1422
34. W.P. O'Meara, D.L. Smith, and F.E. McKenzie Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria PLoS Med 3 2006 e141
35. D.F. Clyde, and G.T. Shute Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals Trans R Soc Trop Med Hyg 51 1957 505 513
36. S. Looareesuwan, C. Viravan, H.K. Webster, D.E. Kyle, D.B. Hutchinson, and C.J. Canfield Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand Am J Trop Med Hyg 54 1996 62 66
37. H. Jiang, J.J. Patel, M. Yi, J. Mu, J. Ding, and R. Stephens Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene PLoS ONE 3 2008 e2484
38. D.I. Andersson, and B.R. Levin The biological cost of antibiotic resistance Curr Opin Microbiol 2 1999 489 493
39. F.P. Mockenhaupt, J. May, Y. Bergqvist, O.G. Ademowo, P.E. Olumese, and A.G. Falusi Concentrations of chloroquine and malaria parasites in blood in Nigerian children Antimicrob Agents Chemother 44 2000 835 839
40. O. Wichmann, T.A. Eggelte, S. Gellert, M.E. Osman, F. Mylius, and S. Ehrhardt High residual chloroquine blood levels in African children with severe malaria seeking healthcare Trans R Soc Trop Med Hyg 101 2007 637 642
41. R.E. Sinden, and P.F. Billingsley Plasmodium invasion of mosquito cells: hawk or dove? Trends Parasitol 17 2001 209 211
42. J.C. Beier, and J.P. Vanderberg Sporogonic development in the mosquito I.W. Sherman, Malaria: parasite biology, pathogenesis, and protection 1998 ASM Press Washington, DC
43. R.E. Sinden Gametocytes and sexual development I.W. Sherman, Malaria: parasite biology, pathogenesis, and protection 1998 ASM Press Washington, DC
44. H.B. Reilly, H. Wang, J.A. Steuter, A.M. Marx, and M.T. Ferdig Quantitative dissection of clone-specific growth rates in cultured malaria parasites Int J Parasitol 37 2007 1599 1607
45. F. ter Kuile, N.J. White, P. Holloway, G. Pasvol, and S. Krishna Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria Exp Parasitol 76 1993 85 95
46. A. Dieckmann, and A. Jung Stage-specific sensitivity of Plasmodium falciparum to antifolates Z Parasitenkd 72 1986 591 594
47. K.I. Barnes, J. Mwenechanya, M. Tembo, H. McLlleron, P.I. Folb, and I. Ribeiro Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study Lancet 363 2004 1598 1605
48. H.A. Karunajeewa, J. Reeder, K. Lorry, E. Dabod, J. Hamzah, and M. Page-Sharp Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea Antimicrob Agents Chemother 50 2006 968 974
49. N.J. White, F. Nosten, D. Waller, J. Crawley, D. Chapman, and D. Brewster Comparison of artemether and chloroquine for severe malaria in Gambian children Lancet 339 1992 317 321
50. A.M. Dondorp, F. Nosten, P. Yi, D. Das, A.P. Phyo, and J. Tarning Artemisinin resistance in Plasmodium falciparum malaria N Engl J Med 361 2009 455 467
51. S. Saralamba, W. Pan-Ngum, R.J. Maude, S.J. Lee, J. Tarning, and N. Lindegårdh Intrahost modeling of artemisinin resistance in Plasmodium falciparum Proc Natl Acad Sci USA 108 2011 397 402
52. L. Schofield, and I. Mueller Clinical immunity to malaria Curr Mol Med 6 2006 205 221
53. J.K. Baird Host age as a determinant of naturally acquired immunity to Plasmodium falciparum Parasitol Today 11 1995 105 111
54. W. Yorke, and J. Macfie Observations on malaria made during treatment of general paralysis Trans R Soc Trop Med Hyg 18 1924 13 33
55. P.B. Bloland, and M. Ettling Making malaria treatment policy in the face of drug resistance Ann Trop Med Parasitol 93 1999 5 23
56. E. Fèvre, and G. Barnish Malaria-treatment policies: when and how should they be changed? Ann Trop Med Parasitol 93 1999 549 560
57. M.J. Mackinnon, and I.M. Hastings The evolution of multiple drug resistance in malaria parasites Trans R Soc Trop Med Hyg 92 1998 188 195
58. A.P. Cross, and B. Singer Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs Trans R Soc Trop Med Hyg 85 1991 349 355
59. I.M. Hastings, W.M. Watkins, and N.J. White The evolution of drug-resistant malaria: the role of drug elimination half-life Philos Trans R Soc Lond B Biol Sci 357 2002 505 519
60. M.L. Gatton, W. Hogarth, and A. Saul Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections Parasitology 123 2003 537 546
61. C.V. Plowe, J.G. Kublin, and O.K. Doumbo P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates Drug Resist Updat 1 1998 389 396
62. E.Y. Klein, D.L. Smith, R. Laxminarayan, and S. Levin Superinfection and the evolution of resistance to antimalarial drugs Proc Biol Sci 279 2012 3834 3842
63. C. Dye, and B. Williams Multigenic drug resistance among inbred malaria parasites Proc Biol Sci 264 1997 61 67
64. E.Y. Klein, D.L. Smith, M.F. Boni, and R. Laxminarayan Clinically immune hosts as a refuge for drug-sensitive malaria parasites Malar J 7 2008 67
65. P.W. Gething, A.P. Patil, D.L. Smith, C.A. Guerra, I.R.F. Elyazar, and G.L. Johnston A new world malaria map: Plasmodium falciparum endemicity in 2010 Malar J 10 2011 378
66. T.E. Wellems, and C.V. Plowe Chloroquine-resistant malaria J Infect Dis 184 2001 770 776
67. J.C. Wootton, X. Feng, M.T. Ferdig, R.A. Cooper, J. Mu, and D.I. Baruch Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum Nature 418 2002 320 323
68. F. Ariey, T. Fandeur, R. Durand, M. Randrianarivelojosia, R. Jambou, and E. Legrand Invasion of Africa by a single pfcrt allele of South East Asian type Malar J 5 2006 34
69. E. Hurwitz, D. Johnson, and C. Campbell Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand Lancet 317 1981 1068 1070
70. J. Verdrager Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia J Trop Med Hyg 89 1986 277 289
71. E. Boudreau, H.K. Webster, K. Pavanand, and L. Thosingha Type II mefloquine resistance in Thailand Lancet 320 1982 1335
72. F. Nosten, F. ter Kuile, T. Chongsuphajaisiddhi, N.J. White, C. Luxemburger, and H.K. Webster Mefloquine-resistant falciparum malaria on the Thai-Burmese border Lancet 337 1991 1140 1143
73. A. Fontanet, D. Johnston, A.M. Walker, W. Rooney, K. Thimasarn, and D. Sturchler High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand Bull World Health Organ 71 1993 377
74. H. Noedl, Y. Se, K. Schaecher, B.L. Smith, D. Socheat, and M.M. Fukuda Evidence of artemisinin-resistant malaria in western Cambodia N Engl J Med 359 2008 2619 2620
75. C.V. Plowe, J.F. Cortese, A. Djimde, O.C. Nwanyanwu, W.M. Watkins, and P.A. Winstanley Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance J Infect Dis 176 1997 1590 1596
76. K. Stepniewska, E. Ashley, S.J. Lee, N. Anstey, K.I. Barnes, and T.Q. Binh In vivo parasitological measures of artemisinin susceptibility J Infect Dis 201 2010 570 579
77. H. Noedl, Y. Se, S. Sriwichai, K. Schaecher, P. Teja-Isavadharm, and B. Smith Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia Clin Infect Dis 51 2010 e82 e89
78. M.W. Service Mosquito (Diptera: Culicidae) dispersal: the long and short of it J Med Entomol 34 1997 579 588
79. M.C. Thomson, S.J. Connor, M.L. Quiñones, M. Jawara, J. Todd, and B.M. Greenwood Movement of Anopheles gambiae s.l. malaria vectors between villages in The Gambia Med Vet Entomol 9 1995 413 419
80. A. LeMenach, F.E. McKenzie, A. Flahault, and D.L. Smith The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission Malar J 4 2005 23
81. M. Isaäcson Airport malaria: a review Bull World Health Organ 67 1989 737 743
82. V.I. Carrara, J. Zwang, E.A. Ashley, R.N. Price, K. Stepniewska, and M. Barends Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment PLoS ONE 4 2009 e4551
83. D. Shahinas, R. Lau, K. Khairnar, D. Hancock, and D.R. Pillai Artesunate misuse and Plasmodium falciparum malaria in traveler returning from Africa Emerg Infect Dis 6 2010 1608 1610
84. R. Jambou, E. Legrand, M. Niang, N. Khim, P. Lim, and B. Volney Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 Lancet 366 2005 1960 1963
85. A. Escalante, D. Smith, and Y. Kim The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum Trends Parasitol 25 2009 557 563
86. I. Hastings How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance Trends Parasitol 27 2011 67 72
87. H. Noedl, D. Socheat, and W. Satimai Artemisinin-resistant malaria in Asia N Engl J Med 361 2009 540 541
88. R. Ross Report on the prevention of malaria in Mauritius 1908 Waterlow and Sons Limited London, UK
89. G. Macdonald The analysis of the sporozoite rate Trop Dis Bull 49 1952 569 586
90. D.L. Smith, K.E. Battle, S.I. Hay, C.M. Barker, T.W. Scott, and F.E. McKenzie Ross, Macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens PLoS Pathog 8 2012 e1002588
91. P. Ehrlich Address in pathology, ON CHEMIOTHERAPY: delivered before the Seventeenth International Congress of Medicine Br Med J 2 1913 353 359
92. R. Laxminarayan Act now or later? Economics of malaria resistance Am J Trop Med Hyg 71 2004 187 195
93. R. Laxminarayan, M. Over, and D.L. Smith Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? Health Aff (Millwood) 25 2006 325 336
94. G. Macdonald The analysis of infection rates in diseases in which superinfection occurs Trop Dis Bull 47 1950 907 915
95. I.M. Hastings Complex dynamics and stability of resistance to antimalarial drugs Parasitology 132 2006 615 624
96. I.M. Hastings, and U. D'Alessandro Modelling a predictable disaster: the rise and spread of drug-resistant malaria Parasitol Today 16 2000 340 347
97. Y. Artzy-Randrup, D. Alonso, and M. Pascual Transmission intensity and drug resistance in malaria population dynamics: implications for climate change PLoS ONE 5 2010 e13588
98. W. Pongtavornpinyo, S. Yeung, I. Hastings, A. Dondorp, N. Day, and N. White Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies Malar J 7 2008 229
99. C. Chiyaka, W. Garira, and S. Dube Effects of treatment and drug resistance on the transmission dynamics of malaria in endemic areas Theor Popul Biol 75 2009 14 29
100. I.M. Hastings, and W.M. Watkins Tolerance is the key to understanding antimalarial drug resistance Trends Parasitol 22 2006 71 77
101. J. Koella, and R. Antia Epidemiological models for the spread of anti-malarial resistance Malar J 2 2003 3
102. C.F. Curtis, and L.N. Otoo A simple model of the build-up of resistance to mixtures of anti-malarial drugs Trans R Soc Trop Med Hyg 80 1986 889 892
103. S.J. Aneke Mathematical modelling of drug resistant malaria parasites and vector populations Math Methods Appl Sci 25 2002 335 346
104. N. Bacaër, and C. Sokhna A reaction-diffusion system modeling the spread of resistance to an antimalarial drug Math Biosci Eng 2 2005 227 238
105. L. Esteva, A.B. Gumel, and C.V. de León Qualitative study of transmission dynamics of drug-resistant malaria Math Comput Model 50 2009 611 630
106. G. Shanks, K. Biomndo, S. Hay, and R. Snow Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands Trans R Soc Trop Med Hyg 94 2000 253 255
107. M.H. Craig, I. Kleinschmidt, D. Le Sueur, and B.L. Sharp Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: part II. The impact of non-climatic factors Trop Med Int Health 9 2004 1258 1266
108. R. Bødker, W. Kisinza, R. Malima, H. Msangeni, and S. Lindsay Resurgence of malaria in the Usambara Mountains, Tanzania, an epidemic of drug-resistant parasites Global Change Hum Health 1 2000 134 153
109. J.R. Zucker, E.M. Lackritz, T.K. Ruebush II, A.W. Hightower, J.E. Adungosi, and J.B.O. Were Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens Am J Trop Med Hyg 55 1996 655 660
110. J.F. Trape, G. Pison, M.P. Preziosi, C. Enel, A. Desgrees du Lou, and V. Delaunay Impact of chloroquine resistance on malaria mortality C R Acad Sci III 321 1998 689 697
111. G.R. Port, P.F.L. Boreham, and J.H. Bryan The relationship of host size to feeding by mosquitoes of the Anopheles gambiae Giles complex (Diptera: Culicidae) Bull Entomol Res 70 1980 133 144
112. S. Wanji, T. Tanke, S.N. Atanga, C. Ajonina, T. Nicholas, and D. Fontenille Anopheles species of the Mount Cameroon region: biting habits, feeding behaviour and entomological inoculation rates Trop Med Int Health 8 2003 643 649
113. I.J. Kligler Further studies on the epidemiology of malaria in Palestine Am J Trop Med Hyg 1 1928 183 198
114. I.J. Kligler The epidemiology and control of malaria in Palestine 1930 University of Chicago Press Chicago, IL
115. R. Lacroix, W.R. Mukabana, L.C. Gouagna, and J.C. Koella Malaria infection increases attractiveness of humans to mosquitoes PLoS Biol 3 2005 e298
116. S. Lindsay, J.H. Adiamah, J.E. Miller, R.J. Pleas, and J.R.M. Armstrong Variation in attractiveness of human subjects to malaria mosquitoes (Diptera: Culicidae) in The Gambia J Med Entomol 30 1993 368 373
117. G. Mer, D. Mirnbaum, and A. Aioub The attraction of mosquitoes by human beings Parasitology 38 1947 1 9
118. B.G.J. Knols, R. de Jong, and W. Takken Differential attractiveness of isolated humans to mosquitoes in Tanzania Trans R Soc Trop Med Hyg 89 1995 604 606
119. S.T. Stoddard, A.C. Morrison, G.M. Vazquez-Prokopec, V.P. Soldan, T.J. Kochel, and U. Kitron The role of human movement in the transmission of vector-borne pathogens PLoS Negl Trop Dis 3 2009 e481
120. M.E.J. Woolhouse, C. Dye, J.F. Etard, T. Smith, J.D. Charlwood, and G.P. Garnett Heterogeneities in the transmission of infectious agents: implications for the design of control programs Proc Natl Acad Sci USA 94 1997 338 342
121. D.L. Smith, C.J. Drakeley, C. Chiyaka, and S.I. Hay A quantitative analysis of transmission efficiency versus intensity for malaria Nat Commun 1 2010 108
122. E. Klein Anti-malarial drug resistance 2012 Princeton University Princeton, NJ
123. P.L. Alonso, J. Sacarlal, J.J. Aponte, A. Leach, E. Macete, and P. Aide Duration of protection with RTS. S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial Lancet 366 2005 2012 2018
124. N.J. White Artemisinin resistance - the clock is ticking Lancet 376 2010 2051 2052